Crossref
Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma
CA: A Cancer Journal for Clinicians · 2026-03 · 76 (2)
DOI: 10.3322/caac.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 20.04.2026. Verfasst von Carrie Printz. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Printz, C. (2026). Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma. CA: A Cancer Journal for Clinicians, 76(2). https://doi.org/10.3322/caac.70078
Vancouver
Printz C. Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma. CA: A Cancer Journal for Clinicians. 2026;76(2). doi:10.3322/caac.70078
BibTeX
@article{Printz2026,
author = {Printz, Carrie},
title = {Radiotherapy followed by adjuvant temozolomide improves survival for patients with aggressive IDH ‐mutated anaplastic glioma},
journal = {CA: A Cancer Journal for Clinicians},
year = {2026},
volume = {76},
number = {2},
doi = {10.3322/caac.70078}
}
EUVIMED